Literature DB >> 33060955

A review of hybrid coronary revascularization.

Michael Owen Kayatta1, Michael Emanuel Halkos1.   

Abstract

PURPOSE: Hybrid coronary revascularization is an emerging treatment strategy for coronary artery disease. We will review the reasons for the development of this strategy, describe surgical techniques, and review outcomes. Finally, we will discuss the future of hybrid revascularization and explain why it will grow as a treatment modality.
METHODS: For this review, we conducted an unstructured review of the literature for articles related to hybrid coronary revascularization, bypass surgery, and percutaneous coronary interventions.
RESULTS: Hybrid coronary revascularization has been shown in large series to have excellent results. These include fast recovery time, low mortality and rates of complications, and excellent surgical graft patency. There may be increased need for revascularization over conventional bypass surgery.
CONCLUSIONS: The combination improved surgical techniques including a robotic surgery platform, as well as the ever-improving efficacy and durability of coronary stents have made hybrid coronary revascularization an attractive option for many patients. It offers a minimally invasive approach to surgery while avoiding the poor patency of saphenous vein grafts. In appropriately selected patients, this may be an ideal treatment strategy that minimizes risks and maximizes short- and long-term benefits. © Indian Association of Cardiovascular-Thoracic Surgeons 2018.

Entities:  

Keywords:  CABG; Hybrid coronary revascularization; PCI

Year:  2018        PMID: 33060955      PMCID: PMC7525882          DOI: 10.1007/s12055-018-0763-7

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  58 in total

1.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.

Authors:  Manesh R Patel; Gregory J Dehmer; John W Hirshfeld; Peter K Smith; John A Spertus; Frederick A Masoudi; Gregory J Dehmer; Manesh R Patel; Peter K Smith; Charles E Chambers; T Bruce Ferguson; Mario J Garcia; Frederick L Grover; David R Holmes; Lloyd W Klein; Marian C Limacher; Michael J Mack; David J Malenka; Myung H Park; Michael Ragosta; James L Ritchie; Geoffrey A Rose; Alan B Rosenberg; Andrea M Russo; Richard J Shemin; William S Weintraub; Michael J Wolk; Steven R Bailey; Pamela S Douglas; Robert C Hendel; Christopher M Kramer; James K Min; Manesh R Patel; Leslee Shaw; Raymond F Stainback; Joseph M Allen
Journal:  J Thorac Cardiovasc Surg       Date:  2012-04       Impact factor: 5.209

2.  A nationwide survey on perception, experience, and expectations of hybrid coronary revascularization among top-ranked US hospitals.

Authors:  Ralf E Harskamp; Michael E Halkos; Ying Xian; Molly A Szerlip; Robert S Poston; Stephanie L Mick; Renato D Lopes; Jan G Tijssen; Robbert J de Winter; Eric D Peterson
Journal:  Am Heart J       Date:  2015-01-07       Impact factor: 4.749

3.  Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

Authors:  Gregg W Stone; Joseph F Sabik; Patrick W Serruys; Charles A Simonton; Philippe Généreux; John Puskas; David E Kandzari; Marie-Claude Morice; Nicholas Lembo; W Morris Brown; David P Taggart; Adrian Banning; Béla Merkely; Ferenc Horkay; Piet W Boonstra; Ad J van Boven; Imre Ungi; Gabor Bogáts; Samer Mansour; Nicolas Noiseux; Manel Sabaté; José Pomar; Mark Hickey; Anthony Gershlick; Pawel Buszman; Andrzej Bochenek; Erick Schampaert; Pierre Pagé; Ovidiu Dressler; Ioanna Kosmidou; Roxana Mehran; Stuart J Pocock; A Pieter Kappetein
Journal:  N Engl J Med       Date:  2016-10-31       Impact factor: 91.245

4.  Video assisted coronary bypass surgery.

Authors:  F J Benetti; C Ballester; G Sani; P Doonstra; J Grandjean
Journal:  J Card Surg       Date:  1995-11       Impact factor: 1.620

Review 5.  Current state of surgical myocardial revascularization.

Authors:  Frank W Sellke; Louis M Chu; William E Cohn
Journal:  Circ J       Date:  2010-05-08       Impact factor: 2.993

6.  Patient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease.

Authors:  Ryan Kipp; James Lehman; Jacqueline Israel; Niloo Edwards; Tara Becker; Amish N Raval
Journal:  Catheter Cardiovasc Interv       Date:  2013-05-06       Impact factor: 2.692

7.  Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.

Authors:  Michael B Rothberg; Senthil K Sivalingam; Javed Ashraf; Paul Visintainer; John Joelson; Reva Kleppel; Neelima Vallurupalli; Marc J Schweiger
Journal:  Ann Intern Med       Date:  2010-09-07       Impact factor: 25.391

8.  Robotic totally endoscopic coronary artery bypass: program development and learning curve issues.

Authors:  J Bonatti; T Schachner; O Bernecker; O Chevtchik; N Bonaros; H Ott; G Friedrich; F Weidinger; G Laufer
Journal:  J Thorac Cardiovasc Surg       Date:  2004-02       Impact factor: 5.209

9.  Hybrid coronary revascularization using robotic totally endoscopic surgery: perioperative outcomes and 5-year results.

Authors:  Johannes O Bonatti; David Zimrin; Eric J Lehr; Mark Vesely; Zachary N Kon; Brody Wehman; Andreas R de Biasi; Benedikt Hofauer; Felix Weidinger; Thomas Schachner; Nikolaos Bonaros; Guy Friedrich
Journal:  Ann Thorac Surg       Date:  2012-10-25       Impact factor: 4.330

10.  Bilateral internal mammary artery grafts, mortality and morbidity: an analysis of 1 526 360 coronary bypass operations.

Authors:  Shinobu Itagaki; Paul Cavallaro; David H Adams; Joanna Chikwe
Journal:  Heart       Date:  2013-03-20       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.